Picher, Ángel J.
Budeus, Bettina
Wafzig, Oliver http://orcid.org/0000-0002-7430-0992
Krüger, Carola
García-Gómez, Sara
Martínez-Jiménez, María I.
Díaz-Talavera, Alberto
Weber, Daniela
Blanco, Luis
Schneider, Armin
Article History
Received: 24 February 2016
Accepted: 21 September 2016
First Online: 29 November 2016
Competing interests
: A.J.P. and L.B. are inventors on patent applications incorporating part of the reported findings. A.J.P., B.B., D.W., O.W., A.S. and C.K. are or were employees of SYGNIS Biotech SLU/SYGNIS Bioscience GmbH & Co KG. L.B. owns shares of SYGNIS A.G. and is a paid advisor to the company. TruePrime is a commercial product line available through SYGNIS or its distributors. The remaining authors declare no competing financial interests.